treatments stat - Robuta Search

https://www.statnews.com/2026/04/24/trump-psychedelic-drugs-fda-priority-review-mental-health-treatment/ FDA fast-tracks review of new psychedelic mental health treatments | STAT Apr 24, 2026 - After Trump administration prodding, FDA offers priority review of psychedelic drugs from Compass Pathways, Usona Institute, and Transcend Therapeutics. fda fast tracks mental health treatments review new psychedelic https://www.statnews.com/2025/12/08/ash-positive-results-leukemia-terns-rival-novartis/ At ASH, positive news for Terns, Kura leukemia treatments | STAT Dec 8, 2025 - The ASH meeting included positive early results about a Terns drug for chronic myeloid leukemia and a Kura menin-blocker for acute myeloid leukemia. positive news treatments stat ash terns kura https://www.statnews.com/2026/04/07/genomic-tests-needed-for-targeted-cancer-treatments/ Study finds missed opportunities for targeted cancer treatments | STAT Apr 13, 2026 - Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival. targeted cancer treatments study finds missed opportunities stat https://www.statnews.com/2026/04/20/trump-executive-order-psychedelics-republicans-veterans-ibogaine/ Republicans missing a key point about psychedelic treatments | STAT Apr 20, 2026 - Psychedelics are not a standalone solution for addiction or trauma. The GOP is pushing drugs while ignoring vital social support and recovery capital. psychedelic treatments republicans missing key point https://www.statnews.com/2026/02/23/fda-rare-disease-new-guidelines-plausible-mechanism-pathway/ FDA unveils new pathway for rare disease treatments | STAT rare disease treatments unveils new fda pathway stat https://www.statnews.com/2026/03/31/baby-kj-gene-editing-fda-rules-pose-expansion-hurdle/ Baby KJ researchers face FDA hurdle on scaling custom treatments | STAT Mar 31, 2026 - After a baby treated by custom gene editing inspired a new FDA pathway, strict FDA manufacturing rules threaten to keep bespoke cures out of reach. baby kj treatments stat researchers face fda https://www.statnews.com/2026/04/21/aacr-2026-pancreatic-cancer-revolution-medicines-future/ Revolution Medicines previews 'novel class' of cancer treatments | STAT Apr 22, 2026 - A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a generation beyond. revolution medicines cancer treatments previews novel class https://www.statnews.com/topic/diabetes/page/2/ STAT Diabetes News - Latest on Research, New Treatments and More Diabetes is a chronic disease that affects millions of people. Stay up-to-date on the latest research on the causes, treatment and prevention of diabetes. research new treatments diabetes news stat latest https://www.statnews.com/2026/01/26/fda-makary-prasad-crispr-gene-editing-concerns-baby-kj/ New FDA pathway for CRISPR treatments raises concerns | STAT Jan 26, 2026 - A new FDA pathway meant to enable one-time gene-editing cures is welcomed in theory but could, ethicists warn, become a Pandora's box. new fda raises concerns pathway crispr treatments https://www.statnews.com/2026/02/20/cancer-immunotherapy-morning-infusions-doubts-about-study/ Study on timing cancer treatments to the morning comes under fire | STAT Feb 21, 2026 - Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the morning. cancer treatments morning comes study timing fire https://www.statnews.com/topic/diabetes/ STAT Diabetes News - Latest on Research, New Treatments and More Diabetes is a chronic disease that affects millions of people. Stay up-to-date on the latest research on the causes, treatment and prevention of diabetes. research new treatments diabetes news stat latest https://www.statnews.com/2026/03/05/better-ibd-treatments-fda-flexibility-questions-readout-loud/ The Readout LOUD: Better IBD treatments and FDA questions | STAT Mar 5, 2026 - Will drugmakers finally be able to breach the efficacy ceiling in inflammatory bowel disease? And is the FDA being flexible enough with rare disease treatments? readout loud better ibd treatments fda